Resultados de procura - Steven M. Devine

Limitar resultados
  1. 1
    Graft-versus-host disease

    Graft-versus-host disease por Samantha Jaglowski, Steven M. Devine

    Publicado 2014
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  2. 2
    Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates

    Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates por Steven M. Devine, Carrington Cobbs, Matt Jennings, Amelia Bartholomew, Ron Hoffman

    Publicado 2003
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  3. 3
    Targeting FLT3 by chimeric antigen receptor T cells for the treatment of acute myeloid leukemia

    Targeting FLT3 by chimeric antigen receptor T cells for the treatment of acute myeloid leukemia por Lichao Chen, Hongyi Mao, Jian Zhang, Jianjun Chu, Steven M. Devine, Michael A. Caligiuri, Jianhua Yu

    Publicado 2017
    Ligazón do recurso
    Carta
    Engadir a favoritos
    Gardado en:
  4. 4
    Existence of HLA-Mismatched Unrelated Donors Closes the Gap in Donor Availability Regardless of Recipient Ancestry

    Existence of HLA-Mismatched Unrelated Donors Closes the Gap in Donor Availability Regardless of Recipient Ancestry por Abu Sayed Chowdhury, Martin Maiers, Stephen R. Spellman, Tushar Deshpande, Yung‐Tsi Bolon, Steven M. Devine

    Publicado 2023
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Stem Cell Mobilization

    Stem Cell Mobilization por Michele Cottler‐Fox, Tsvee Lapidot, Isabelle Petit, Órit Kollet, John F. DiPersio, Dan Link, Steven M. Devine

    Publicado 2003
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  6. 6
    Comorbidities, Not Age, Impact Outcomes in Autologous Stem Cell Transplant for Relapsed Non-Hodgkin Lymphoma

    Comorbidities, Not Age, Impact Outcomes in Autologous Stem Cell Transplant for Relapsed Non-Hodgkin Lymphoma por Tanya M. Wildes, Kristan Augustin, Diane S. Sempek, Qin Jean Zhang, Ravi Vij, John F. DiPersio, Steven M. Devine

    Publicado 2008
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    The relative quiescence of hematopoietic stem cells in nonhuman primates

    The relative quiescence of hematopoietic stem cells in nonhuman primates por Nadim Mahmud, Steven M. Devine, Kevin P. Weller, Simrit Parmar, Cord Sturgeon, Mary C. Nelson, Terry A. Hewett, Robert S. Hoffman

    Publicado 2001
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100

    Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100 por Rebecca M. Shepherd, Benjamin J. Capoccia, Steven M. Devine, John F. DiPersio, Kathryn Trinkaus, David A. Ingram, Daniel C. Link

    Publicado 2006
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    Rapid Mobilization of CD34+ Cells Following Administration of the CXCR4 Antagonist AMD3100 to Patients With Multiple Myeloma and Non-Hodgkin's Lymphoma

    Rapid Mobilization of CD34+ Cells Following Administration of the CXCR4 Antagonist AMD3100 to Patients With Multiple Myeloma and Non-Hodgkin's Lymphoma por Steven M. Devine, Neal Flomenberg, David H. Vesole, Jane L. Liesveld, Daniel J. Weisdorf, Karin Badel, Gary Calandra, John F. DiPersio

    Publicado 2004
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    Survival of Patients with Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Study

    Survival of Patients with Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Stud... por Nelli Bejanyan, Daniel J. Weisdorf, Brent R. Logan, Hai-Lin Wang, Steven M. Devine, Marcos de Lima, Donald Bunjes, Mei-Jie Zhang

    Publicado 2014
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    Vedolizumab for prevention of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

    Vedolizumab for prevention of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation por Yi‐Bin Chen, Nirav N. Shah, Anne S. Renteria, Corey Cutler, Johan Jansson, Mona Akbari, Chunlin Chen, Syed M. Quadri, Andrejus Parfionovas, Steven M. Devine

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    Human Progenitor Cells Rapidly Mobilized by AMD3100 Repopulate NOD/SCID Mice with Increased Frequency in Comparison to Cells from the Same Donor Mobilized by Granulocyte Colony Stimulating Factor

    Human Progenitor Cells Rapidly Mobilized by AMD3100 Repopulate NOD/SCID Mice with Increased Frequency in Comparison to Cells from the Same Donor Mobilized by Granulocyte Colony Sti... por David A. Hess, Jesper Bonde, Timothy C. Craft, Louisa Wirthlin, Sarah Hohm, Ryan Lahey, Laura Todt, John F. DiPersio, Steven M. Devine, Jan A. Nolta

    Publicado 2007
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    Single and Multiple Dose MultiStem (Multipotent Adult Progenitor Cell) Therapy Prophylaxis of Acute Graft-versus-Host Disease in Myeloablative Allogeneic Hematopoietic Cell Transplantation: A Phase 1 Trial

    Single and Multiple Dose MultiStem (Multipotent Adult Progenitor Cell) Therapy Prophylaxis of Acute Graft-versus-Host Disease in Myeloablative Allogeneic Hematopoietic Cell Transpl... por Richard T. Maziarz, Timothy Devos, Carlos Bachier, Steven C. Goldstein, José F. Leis, Steven M. Devine, Gabrielle Meyers, James Gajewski, Johan Maertens, Robert Deans, Wouter van’t Hof, Hillard M. Lazarus

    Publicado 2014
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    Complex karyotype predicts for inferior outcomes following reduced‐intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia

    Complex karyotype predicts for inferior outcomes following reduced‐intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia por Samantha Jaglowski, Amy S. Ruppert, Nyla A. Heerema, Anissa Bingman, Joseph M. Flynn, Michael R. Grever, Jeffrey A. Jones, Patrick Elder, Steven M. Devine, John C. Byrd, Leslie A. Andritsos

    Publicado 2012
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    Recommendations for Donor Human Leukocyte Antigen Assessment and Matching for Allogeneic Stem Cell Transplantation: Consensus Opinion of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)

    Recommendations for Donor Human Leukocyte Antigen Assessment and Matching for Allogeneic Stem Cell Transplantation: Consensus Opinion of the Blood and Marrow Transplant Clinical Tr... por Carol A. Howard, Marcelo Fernández-Viña, Frederick R. Appelbaum, Dennis L. Confer, Steven M. Devine, Mary M. Horowitz, Adam Mendizabal, Ginna G. Laport, Marcelo C. Pasquini, Stephen R. Spellman

    Publicado 2014
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  16. 16
    Allogeneic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasia

    Allogeneic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasia por Steven M. Devine, Ron Hoffman, Amit Verma, Rajul Shah, Basil A. Bradlow, Wendy Stock, Vera Maynard, E Jessop, David Peace, Marianne Huml, Deana Thomason, Yi-Hsiang Chen, Koen van Besien

    Publicado 2002
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  17. 17
    Clinical impact of<i>ABL1</i>kinase domain mutations and<i>IKZF1</i>deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665

    Clinical impact of<i>ABL1</i>kinase domain mutations and<i>IKZF1</i>deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL):... por Rebecca DeBoer, Gregory Koval, Flora Mulkey, Meir Wetzler, Steven M. Devine, Guido Marcucci, Richard M. Stone, Richard A. Larson, Clara D. Bloomfield, Susan Geyer, Charles G. Mullighan, Wendy Stock

    Publicado 2016
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  18. 18
    Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction

    Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction por Steven M. Devine, Ravi Vij, Michael P. Rettig, Laura Todt, Kiley McGlauchlen, Nicholas M. Fisher, Hollie Devine, Daniel C. Link, Gary Calandra, Gary Bridger, Peter Westervelt, John F. DiPersio

    Publicado 2008
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  19. 19
    Midostaurin, bortezomib and MEC in relapsed/refractory acute myeloid leukemia

    Midostaurin, bortezomib and MEC in relapsed/refractory acute myeloid leukemia por Alison R. Walker, Hongyan Wang, Katherine Walsh, Bhavana Bhatnagar, Sumithira Vasu, Ramiro Garzon, Renee Canning, Susan M. Geyer, Yue-Zhong Wu, Steven M. Devine, Rebecca B. Klisovic, William Blum, Guido Marcucci

    Publicado 2016
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  20. 20
    Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and High-Dose Rituximab for Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma: A Phase Two Multicenter Trial from the Blood and Marrow Transplant Clinical Trials Network

    Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and High-Dose Rituximab for Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma: A Phase Two Mu... por Ginna G. Laport, Juan Wu, Brent R. Logan, Veronika Bachanová, Chitra Hosing, Timothy S. Fenske, Walter Longo, Steven M. Devine, Auayporn Nademanee, Iris D. Gersten, Mary M. Horowitz, Hillard M. Lazarus, Marcie Riches

    Publicado 2016
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: